Literature DB >> 14983024

Negative regulation of IFN-alpha/beta signaling by IFN regulatory factor 2 for homeostatic development of dendritic cells.

Kenya Honda1, Tatsuaki Mizutani, Tadatsugu Taniguchi.   

Abstract

The development and cooperation of distinct subsets of antigen-presenting cells, particularly dendritic cells (DCs), may be critical for maintaining homeostatic immune responses. Recently, much attention has been focused on IFN-alpha/beta, the cytokines induced en masse by virus infection or the activation of Toll-like receptors, in the context of DC activation. Here, we show that mice deficient in IFN regulatory factor 2 exhibit selective loss of CD8alpha- DCs, the so-called myeloid DCs, which is accompanied by a notable increase in CD11c-CD11bhigh other myeloid lineage cells. Such deficiency is intrinsic to the bone marrow precursors, in which the abnormal induction of IFN-alpha/beta genes causes excessive IFN signaling. The critical function of IFN regulatory factor 2 in the negative regulation of IFN-alpha/beta signaling is underscored by the observation that the deficiency is rescued by introducing an additional null mutation for the IFN receptor complex. In view of accumulating evidence of the critical role of IFN-alpha/beta signaling in DC activation, our present study offers a unique example in that the magnitude of a cytokine signal should be properly balanced in a stage-specific manner during the differentiation and activation of DCs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14983024      PMCID: PMC356965          DOI: 10.1073/pnas.0307336101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

Review 1.  Interferons alpha and beta as immune regulators--a new look.

Authors:  C A Biron
Journal:  Immunity       Date:  2001-06       Impact factor: 31.745

2.  Identification of CD8alpha+CD11c- lineage phenotype-negative cells in the spleen as committed precursor of CD8alpha+ dendritic cells.

Authors:  Yong Wang; Yanyun Zhang; Hiroyuki Yoneyama; Nobuyuki Onai; Taku Sato; Kouji Matsushima
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

3.  Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology.

Authors:  C Asselin-Paturel; A Boonstra; M Dalod; I Durand; N Yessaad; C Dezutter-Dambuyant; A Vicari; A O'Garra; C Biron; F Brière; G Trinchieri
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

Review 4.  Mouse and human dendritic cell subtypes.

Authors:  Ken Shortman; Yong-Jun Liu
Journal:  Nat Rev Immunol       Date:  2002-03       Impact factor: 53.106

5.  Impaired class II transactivator expression in mice lacking interferon regulatory factor-2.

Authors:  H Xi; B Goodwin; A T Shepherd; G Blanck
Journal:  Oncogene       Date:  2001-07-12       Impact factor: 9.867

6.  Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction.

Authors:  M Sato; H Suemori; N Hata; M Asagiri; K Ogasawara; K Nakao; T Nakaya; M Katsuki; S Noguchi; N Tanaka; T Taniguchi
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

7.  IFNs activate toll-like receptor gene expression in viral infections.

Authors:  M Miettinen; T Sareneva; I Julkunen; S Matikainen
Journal:  Genes Immun       Date:  2001-10       Impact factor: 2.676

8.  Essential role for ICSBP in the in vivo development of murine CD8alpha + dendritic cells.

Authors:  Julio Aliberti; Oliver Schulz; Daniel J Pennington; Hideki Tsujimura; Caetano Reis e Sousa; Keiko Ozato; Alan Sher
Journal:  Blood       Date:  2002-06-28       Impact factor: 22.113

9.  Functional role of type I and type II interferons in antiviral defense.

Authors:  U Müller; U Steinhoff; L F Reis; S Hemmi; J Pavlovic; R M Zinkernagel; M Aguet
Journal:  Science       Date:  1994-06-24       Impact factor: 47.728

10.  ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells.

Authors:  Giovanna Schiavoni; Fabrizio Mattei; Paola Sestili; Paola Borghi; Massimo Venditti; Herbert C Morse; Filippo Belardelli; Lucia Gabriele
Journal:  J Exp Med       Date:  2002-12-02       Impact factor: 14.307

View more
  28 in total

Review 1.  Transcriptional programming of the dendritic cell network.

Authors:  Gabrielle T Belz; Stephen L Nutt
Journal:  Nat Rev Immunol       Date:  2012-01-25       Impact factor: 53.106

Review 2.  Regulation of T helper cell differentiation by interferon regulatory factor family members.

Authors:  Ruihua Zhang; Kang Chen; Liang Peng; Huabao Xiong
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

3.  Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection.

Authors:  Elina I Zuniga; Dorian B McGavern; Jose L Pruneda-Paz; Chao Teng; Michael B A Oldstone
Journal:  Nat Immunol       Date:  2004-11-07       Impact factor: 25.606

4.  Transcriptional regulation of lipopolysaccharide (LPS)-induced Toll-like receptor (TLR) expression in murine macrophages: role of interferon regulatory factors 1 (IRF-1) and 2 (IRF-2).

Authors:  Quan M Nhu; Natalia Cuesta; Stefanie N Vogel
Journal:  J Endotoxin Res       Date:  2006

Review 5.  The IRF family, revisited.

Authors:  A Paun; P M Pitha
Journal:  Biochimie       Date:  2007-02-20       Impact factor: 4.079

Review 6.  A STATus report on DC development.

Authors:  Haiyan S Li; Stephanie S Watowich
Journal:  J Leukoc Biol       Date:  2012-05-01       Impact factor: 4.962

7.  The NS2 protein of human respiratory syncytial virus suppresses the cytotoxic T-cell response as a consequence of suppressing the type I interferon response.

Authors:  Alexander Kotelkin; Igor M Belyakov; Lijuan Yang; Jay A Berzofsky; Peter L Collins; Alexander Bukreyev
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

8.  Deficiency of type I IFN receptor in lupus-prone New Zealand mixed 2328 mice decreases dendritic cell numbers and activation and protects from disease.

Authors:  Hemant Agrawal; Noam Jacob; Esther Carreras; Sandra Bajana; Chaim Putterman; Sean Turner; Barbara Neas; Alexis Mathian; Michael N Koss; William Stohl; Susan Kovats; Chaim O Jacob
Journal:  J Immunol       Date:  2009-10-07       Impact factor: 5.422

9.  TRIM13 is a negative regulator of MDA5-mediated type I interferon production.

Authors:  Kavitha Narayan; Lisa Waggoner; Serena T Pham; Gabriel L Hendricks; Stephen N Waggoner; Joseph Conlon; Jennifer P Wang; Katherine A Fitzgerald; Joonsoo Kang
Journal:  J Virol       Date:  2014-07-09       Impact factor: 5.103

10.  Induction of IFN-beta and the innate antiviral response in myeloid cells occurs through an IPS-1-dependent signal that does not require IRF-3 and IRF-7.

Authors:  Stephane Daffis; Mehul S Suthar; Kristy J Szretter; Michael Gale; Michael S Diamond
Journal:  PLoS Pathog       Date:  2009-10-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.